EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SAM-AMP lyases in type III CRISPR defence

Haotian Chi, Stephen McMahon, Lukas Daniel-Pedersen, Shirley Graham, Tracey M Gloster iD, Malcolm F White iD

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Haotian Chi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology, University of St Andrews, St Andrews, Fife KY16 9ST, United Kingdom. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Bacterial Proteins, Lyases. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, European Research Council Advanced Grant, University of St Andrews.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type III CRISPR systems detect non-self RNA and activate the enzymatic Cas10 subunit, which generates nucleotide second messengers for activation of ancillary effectors. Although most signal via cyclic oligoadenylate, an alternative class of signalling molecule SAM-AMP, formed by conjugating ATP and S-adenosylmethionine, was described recently. SAM-AMP activates a trans-membrane effector of the CorA magnesium transporter family to provide anti-phage defence. Intriguingly, immunity also requires SAM-AMP degradation by means of a specialized CRISPR-encoded NrN family phosphodiesterase in Bacteroides fragilis. In Clostridium botulinum, the nrn gene is replaced by a gene encoding a SAM-AMP lyase. Here, we investigate the structure and activity of C. botulinum SAM-AMP lyase, which can substitute for the nrn gene to provide CorA-mediated immunity in Escherichia coli. The structure of SAM-AMP lyase bound to its reaction product 5′-methylthioadenosine-AMP reveals key details of substrate binding and turnover by this PII superfamily protein. Bioinformatic analysis revealed a phage-encoded SAM-AMP lyase that degrades SAM-AMP efficiently in vitro, consistent with an anti-CRISPR function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsBacterial ProteinsLyasesS-AdenosylmethionineEscherichia coliThionucleosidesModels, MolecularDeoxyadenosinesCrystallography, X-Ray

Substanzen

S-AdenosylmethionineBacterial ProteinsThionucleosides5'-methylthioadenosineLyasesDeoxyadenosines

Autor:innen und Institutionen

  • School of Biology, University of St Andrews, St Andrews, Fife KY16 9ST, United Kingdom.

ORCID-Profile: Tracey M Gloster, Malcolm F White

Förderung

  • Biotechnology and Biological Sciences Research Council
  • European Research Council Advanced Grant
  • University of St Andrews

Zitieren

APA

Chi, H., McMahon, S., Daniel-Pedersen, L., Graham, S., Gloster, T. M., & White, M. F. (2025). SAM-AMP lyases in type III CRISPR defence. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf655

Vancouver

Chi H, McMahon S, Daniel-Pedersen L, Graham S, Gloster TM, White MF. SAM-AMP lyases in type III CRISPR defence. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf655

BibTeX
@article{Chi2025,
  author = {Chi, Haotian and McMahon, Stephen and Daniel-Pedersen, Lukas and Graham, Shirley and Gloster, Tracey M and White, Malcolm F},
  title = {SAM-AMP lyases in type III CRISPR defence},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf655}
}
Kostenlos starten →